Analog DevicesADPA9007ACGZNRF Amplifiers

RF Amp Single Power Amp 31GHz 15V 32-Pin LFCSP EP Cut Tape

ADPA9007: DC to 28 GHz, GaAs, pHEMT, 2 W Power Amplifier

The ADPA9007 is a 2 W RF power amplifier that operates from DC to 28 GHz. The RF input and output are internally-matched and DC-coupled. The ADPA9007 includes an integrated temperature-compensated RF power detector and an integrated temperature sensor.

The ADPA9007 amplifier provides a gain of 12.5 dB, an output power for 1 dB compression (OP1dB) of 33 dBm, and an output third-order intercept (OIP3) of 45 dBm from 2 GHz to 16 GHz. The amplifier operates from a typical supply voltage of 15 V and has a 500 mA typical quiescent bias current, which is adjustable.

The ADPA9007 is fabricated on a gallium arsenide (GaAs), pseudomorphic high electron mobility transistor (pHEMT) process. The amplifier is housed in an RoHS-compliant, 32-Lead, 5 mm × 5 mm, lead frame chip scale package, premolded cavity [LFCSP_CAV] and is specified for operation from −40°C to +85°C.



Key Features and Benefits

  • •  Wideband, internally-matched, RF power amplifier
  • •  DC-coupled input and output
  • •  Integrated RF power detector
  • •  Integrated temperature sensor
  • •  Gain: 12.5 dB typical at 2 GHz to 16 GHz
  • •  OP1dB: 33 dBm typical at 2 GHz to 16 GHz
  • •  PSAT: 34 dBm typical at 2 GHz to 16 GHz
  • •  OIP3: 45 dBm typical at 2 GHz to 16 GHz
  • •  32-Lead, 5.00 mm × 5.00 mm, LFCSP_CAV package


Applications

  • •  Electronic warfare
  • •  Radar
  • •  Test and measurement equipment


Evaluation Board

The ADPA9007 can be evaluated with the ADPA9007-EVALZ.



Block Diagrams and Tables










3 parts: Ships in 2 days

    Total$138.76Price for 1

    • Ships in 2 days

      Ships from:
      United States of America
      Date Code:
      2344+
      Manufacturer Lead Time:
      10 weeks
      Country Of origin:
      Taiwan
      • In Stock: 3 parts
      • Price: $138.76

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.